Sera Prognostics (SERA) Announces 4.7M Share IPO at $15-$17/sh

Sera Prognostics (NASDAQ: SERA) announces 4,687,500 share IPO at $15-$17 per share.

The company describes itself as: "We are a women’s health diagnostic company utilizing our proprietary proteomics and bioinformatics platform to discover, develop and commercialize clinically meaningful and economically impactful biomarker tests, with an initial focus on improving pregnancy outcomes. We believe that our method of combining the disciplines of proteomics and bioinformatics with rigorous clinical testing and economic analysis enables us to provide physicians and patients with actionable data and information designed to result in better maternal and neonatal health at lower cost. "

Citigroup​​, Cowen and William Blair will serve as underwriters.
​

You May Also Be Interested In

• CoVolt Power files for proposed IPO
• SERA PROGNOSTICS APPOINTS SCOTT GLEASON CHIEF FINANCIAL OFFICER
• SU Group wins exclusive Macao rights for high-mast inspection robot